Skip to main content
. 2017 Dec 27;57(9):1291–1296. doi: 10.2169/internalmedicine.9484-17

Table 1.

Laboratory Data on Admission.

Complete blood cell count Blood chemistry Immunologic test
White blood cell 10,400 /μL Total protein 5.8 g/dL RF 4 IU/mL
Neutrophil 76.2 % Albumin 2.1 g/dL IgG 1,329 mg/dL
Lymphocyte 14.6 % Total bilirubin 1 mg/dL IgG4 22.5 mg/dL
Eosinophil 0.6 % AST 12 U/L IgA 213 mg/dL
Basophil 0.5 % ALT 5 U/L IgM 93 mg/dL
Monocyte 8.1 % LDH 334 U/L ANA <×40
Red blood cell 478×104 /μL ALP 880 U/L anti-ds-DNA IgG -
Hemoglobin 12.9 g/dL γ-GTP 149 U/L PR3-ANCA 0.8 IU/mL
Hematocrit 37.8 % BUN 38 mg/dL MPO-ANCA <0.5 IU/mL
Platelet 7.8×104 /μL Creatinine 2.8 mg/dL Direct Coombs test -
CRP 15.23 mg/dL PA-IgG 16.2 ng/107 cells
Glucose 124 mg/dL
Coagulation system
PT 14.6 sec Cytokines Pleural effusion
PT-INR 1.22 sIL-2R 800 U/mL Total protein 3 g/dL
APTT 29.9 sec IL-6 26.6 pg/mL LDH 101 U/L
Fibrinogen 539 mg/dL VEGF 107 pg/mL Cell count 106 /μL
FDP 60.7 μg/mL Lymphocyte 72.6 %
D-dimer 17 μg/mL Urine test Monocyte 24.4 %
Antithrombin III 74.6 % Protein 2+ Mesothelial cell 2.6 %
TAT 5.4 ng/mL Glucose - Eosinophil 0.4 %
soluble fibrin monomer 4.9 μg/mL Occult blood 2+
PIC 5.6 μg/mL Granular cast -

PT: prothrombin time, PT-INR: prothrombin time-international normalized ratio, APTT: activated partial thromboplastin time, FDP: fibrinogen degradation products, TAT: thrombin- antithrombin complex, PIC: plasmin-α2 plasmin inhibitor complex, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, γ-GTP: γ-glutamyl transpeptidase, BUN: blood urea nitrogen, CRP: C-reactive protein, sIL-2R: soluble interleukin-2 receptor, IL-6: interleukin-6, VEGF: vascular endothelial growth factor, RF: rheumatoid factor, ANA: antinuclear antibody, anti-dsDNA IgG: anti-double-stranded DNA IgG antibody, PR3-ANCA: proteinase 3-anti neutrophil cytoplasmic antibody, MPO-ANCA: myeloperoxidase-anti neutrophil cytoplasmic antibody, PA-IgG: platelet-associated IgG